SOURCE: Vaezi MF et al. Clin Gastroenterol Hepatol. 2018 Feb 7. doi: 10.1016/j.cgh.2018.02.001.
From the AGA Journals
AGA Clinical Practice Update: Extraesophageal symptoms attributed to GERD
More Upper GI Tract News
- Angiotensin Receptor Blockers May Lead to Worse Outcomes in Celiac Disease
- Liquid Fasting Mitigates Negative Pre-Surgery Impact of Semaglutide
- GLP-1 RAs Safe in the Perioperative Period: New Guidance
- Shorter H pylori Treatment With Vonoprazan Shows Better Results
- Weight Loss Surgery, Obesity Drugs Achieve Similar Results but Have Different Safety Profiles
- Medical, Endoscopic, and Surgical Management of Gastroesophageal Reflux Disease
- Cendakimab That Targets IL-13 Shows Promise in Eosinophilic Esophagitis
- Vonoprazan Offers PPI Alternative for Heartburn with Non-Erosive Reflux
Question 1 of 4